J Lin, L Xia, L Oyang, J Liang, S Tan,
N Wu, P Yi, Q Pan… - Oncogene, 2022 - nature.com
Cancer metabolic reprogramming enhances its malignant behaviors and drug resistance,
which is regulated by POU domain transcription factors. This study explored the effect of …